Centella asiatica is a medicinal plant used to enhance memory. We have previously shown that a water extract of Centella asiatica (CAW) attenuates β-amyloid (Aβ)-induced spatial memory deficits in mice and improves neuronal health. Yet the effect of CAW on other cognitive domains remains unexplored as does its in vivo mechanism of improving Aβ-related cognitive impairment. This study investigates the effects of CAW on learning, memory and executive function as well as mitochondrial function and antioxidant response in the 5xFAD model of Aβ accumulation.
expression in the brain are thought to precede, or even induce, cognitive decline in AD (Brown and Borutaite, 2002; Manczak et al., 2004; Yao et al., 2009; Swerdlow, 2018) and increased oxidative stress is similarly considered to be an early event in the brains of AD patients (Serrano and Klann, 2004; Lovell and Markesbery, 2007) . These abnormalities have been observed in many mouse models of AD (Oakley et al., 2006; Du et al., 2010; Cuadrado-Tejedor et al., 2013; BilkeiGorzo, 2014) .
The plant Centella asiatica (L) Urban (Apiaceae), also known as Gotu Kola, is used in traditional Chinese and Ayurvedic medicine to improve cognitive function and reverse cognitive impairments (Shinomol and Bharath, 2011) . The neuroprotective and cognitive enhancing effects of Centella asiatica have been well-documented in in a variety of in vitro and in vivo models of neurodegenerative disease and in the setting of neurotoxic insults (Soumyanath et al., 2005; Gupta and Flora, 2006; Tabassum et al., 2013; Lokanathan et al., 2016) . Studies from our own lab have shown that a water extract of Centella asiatica (CAW) attenuates Aβ-induced mitochondrial dysfunction and oxidative stress in vitro (Gray et al., 2015; Gray et al., 2017b) and can improve spatial memory in the animals (Soumyanath et al., 2012) . We have also recently found that CAW treatment can increase synaptic density and improve executive function in healthy aged mice . Executive function includes behaviors like attentional selection, behavioral inhibition, cognitive flexibility, task switching, planning and decisionmaking and is an early marker of cognitive impairment in AD patients (Buckner, 2004 ). Yet the effects of CAW on executive function have not been evaluated in Aβ-overexpressing mice nor have its in vivo effects on mitochondrial function, oxidative stress and synaptic endpoints been investigated in this pathological context. This study aims to address these gaps in understanding and provide evidence for the therapeutic utility of CAW by examining the effects of the extract in the 5xFAD mouse model of Aβ-accumulation.
Materials and methods

CAW
Dried Centella asiatica aerial parts (lot number 170300206; country of origin India; harvest date 2015) was purchased from Oregon's Wild Harvest, Redmond, OR. The water extract of Centella asiatica (CAW) was prepared as previously described (Gray et al., 2016) . Briefly, a total of 1200 g raw plant material was refluxed with 15 L of water for 1.5 h, in several small batches. After filtering the extract to remove plant debris, the liquid was freeze dried to produce 245 g of CAW powder. A voucher specimen of the plant material and the CAW are deposited in our laboratory and stored at -20C.
Animals
5xFAD mice were generated from a breeding pair obtained from The Jackson Laboratory. These mice overexpress human amyloid precursor protein (APP) and human presenilin 1 (PS1) with five mutations associated with familial Alzheimer's Disease: the Swedish (K670N, M671L) Florida (I716V) and London (V717I) mutations in APP as well as two in PS1 (M146L and L286V) (Oakley et al., 2006) . Following weaning, litters were genotyped and group housed (4-5 per cage) until the commencement of experiments. Mice were maintained in a climatecontrolled environment with a 12-h light/12-h dark cycle. Diet and water were supplied ad libitum, except during behavioral testing. All procedures were conducted in accordance with the NIH Guidelines for the Care and Use of Laboratory Animals and were approved by the institutional Animal Care and Use Committee of the Portland VA Medical Center.
Seven month old female 5xFAD mice and their female WT littermates were either exposed to CAW in their drinking water at 2 g/L or to untreated water for two weeks prior to the beginning of behavioral testing and throughout the tests. Water consumption was monitored throughout the experiment to ensure the addition of CAW did not affect overall water intake. Following 3 weeks of behavioral testing animals were sacrificed and tissue harvested as outlined in Fig. 1. 
Behavioral testing
Conditioned Fear Response (CFR): This test consists of three phases: habituation, conditioning and testing. During the habituation phase, animals are exposed to a 16 × 16 × 12 inch test chamber for 5 min. Immediately following habituation, 3 one-second shocks (0.7 mA) are randomly administered over a 3 min period, with no more than one shock per minute. The test phase occurs 24 h later where animals are reintroduced to the test chamber for 5 min with no shock. Freezing behavior in the test phase is recorded. Baseline freezing, during the habituation phase, is subtracted.
Object Location Memory (OLM): This test also consists of three phases: habituation, training and testing. During habituation each mouse is placed in a square arena (38 × 38 × 64 cm high, constructed of white acrylonitrile butadiene styrene) for two 10 min open field sessions on two consecutive days. During the training phase animals are exposed to two identical objects in fixed locations for 10 min, once an hour for 3 h. The testing phase occurs 2 h following the final training phase. In the testing one object is displaced to a novel spatial location and the mouse is allowed to explore the environment for 5 min. Time spent exploring the displaced and non-displaced objects is measured via a camera mounted above the arena, interfaced with ANYmaze video tracking system (Stoelting Co, Wood Dale, IL).
Odor discrimination reversal learning (ODRL): This test has three phases: shaping, acquisition and shift. In the shaping phase mice are Fig. 1 . Timeline of CAW treatment and behavioral assessment. Mice were treated with CAW (2 g/L) two weeks prior to the beginning of behavioral testing and treatment continued throughout the experiment. After testing, animals were sacrificed and tissue was harvested. CAW treatment lasted a total of 5 weeks.
N.E. Gray et al. Molecular and Cellular Neuroscience 93 (2018) 1-9 introduced to the testing chamber and trained to dig for a food reward in lavender scented bedding material. Mice are presented with a single bowl containing the food reward that was progressively filled with bedding in five stages, 0%, 25%, 50%, 75% and 100% filled. The mouse advances to the subsequent training step when it has successfully retrieved the food reward 5 times in a row. The acquisition phase begins after mice had completed the shaping phase. In this phase mice are presented with two cups one containing dried beans and the other string. In every trial one digging material has a vanilla odor and the other a mint odor and the odor and material pairings were randomly alternated between trials but balanced over the acquisition phase so that each mouse is exposed to roughly equal combinations of each odor and digging material. Whether the baited cup is presented on the right or left side of the apparatus is also balanced throughout testing. In the acquisition phase the mint-scented bowl is always baited regardless of digging material. Example trials are found in Table 1 . Each trial is initiated by raising the divider and allowing access to both bowls. Mice are required to make 8 correct digs in any bout of 10 in order to reach criteria. Trials to reach criteria is recorded.
After a mouse reaches criteria in the acquisition phase they immediately proceed to the shift phase. As in the previous phase in the shift phase mice are presented with two cups one containing dried beans and the other string. In every trial one digging material has the vanilla odor and the other the mint odor and again the odor + digging material pairings are balanced throughout the trial as is right/left location of the baited cup. In the shift phase however the cup with the dried beans is always baited regardless of odor. Again criteria is defined as 8 correct trials in any bout of 10 and trials to criteria are recorded. Mice are food restricted the night before each phase of the ODRL in order to motivate the animals.
Isolation of hippocampal mitochondria
Hippocampal mitochondria were isolated using a previously described protocol (Iuso et al., 2017) with slight modifications. Briefly, isolated hippocampi were placed in cold isolation buffer containing 220 mM mannitol, 70 mM sucrose, 5 mM KH2PO4, 5 mM MgCl2, 2 mM HEPES, 1 mM EGTA and 0.5% BSA (fatty acid free) and homogenized using an Arrow Engineering JR4000 homogenizer. Homogenate was centrifuged at 500g for 5 min at 4C. The supernatant fraction was then isolated and centrifuged at 14,000g for 10 min at 4C. Then the pellet fraction was resuspended in 12% Percoll and carefully layered on top of 24% Percoll and centrifuged at 16,000g for 20 min at 4C. Protein concentration was assessed by a Bradford Assay.
Analysis of mitochondrial function
Mitochondrial function was assessed using the Seahorse Bioscience XF24 Extracellular Flux Analyzer. Isolated mitochondria were plated on Seahorse XF culture plates (Seahorse Bioscience) at a concentration of 2 μg/well with 3-4 replicate wells per animal. The plate was centrifuged for 15 min at 2000 ×g and oxygen consumption rates (OCR) were measured under varying conditions using the MitoStress Kit as previously described (Iuso et al., 2017) . After three initial baseline measurements of OCR, a saturating concentration of ADP (2 mM) was added to ensure maximum state III respiration and three subsequent measurements were taken. This was followed by the addition of the ATP synthase inhibitor oligomycin (2 μM) to induce state IV respiration and three additional measurements were taken. Next an electron transport chain (ETC) accelerator carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone (FCCP at 4 μM), was added to induce maximal uncoupled (state IIIu) respiration and after 3 measurements were taken, mitochondrial inhibitors rotenone (1 μM) and antimycin (1 μM) were added, and three final measurements were taken.
Immunohistochemistry
Postmortem, the each hemisphere of the brain was separated for each animal. One hemisphere was fixed in 4% paraformaldehyde and then passed through a sucrose gradient, and frozen. Forty micron frozen coronal sections were then cut on a freezing microtome. Sections were incubated with agitation in blocking buffer (100 mM TBS, pH 8.0, 2 mg/ml bovine serum albumin, 2% horse serum, 0.5% Triton X-100) for 2 h, then incubated overnight with primary antibody diluted 1:1000 in blocking buffer (rabbit polyclonal antibodies directed against either Aβ or human AβPP (Invitrogen). Sections were then incubated for 2 h with biotinylated secondary antibody (1:200, Vector Labs, Burlingame, CA), for 2 h with an avidin-linked peroxidase complex (ABC, Vector Labs), then developed with diaminobenzidine (DAB, Sigma) in PBS. Sections were washed, mounted in Permount (Fisher Scientific, Pittsburg, PA) and cover slipped. Protein expression was quantified in at least three coronal sections from each mouse, representing anterior, middle and posterior hippocampus and cortex. Hippocampal and cortical areas were traced using a computerized stage and stereo investigator software (Image J, Wayne Rasband, NIH, USA). Aβ levels were expressed as percentage of hippocampus or cortex occupied by these plaques. Mean values for each parameter were calculated from at least three sections per animal.
Gene expression
Hippocampal, and cortical was homogenized and RNA was extracted using Tri-Reagent (Molecular Research Center). RNA was reverse transcribed with the Superscript III First Strand Synthesis kit (Invitrogen) to generate cDNA as per the manufacturer's instructions. Relative gene expression was determined using TaqMan Gene Expression Master Mix (Invitrogen) and commercially available TaqMan primers (Invitrogen) for synaptophysin, post-synaptic density protein 95 (PSD95), mitochondrially encoded NADH dehydrogenase 1 (MtND1), mitochondrially encoded cytochrome B (Mt-CYB), mitochondrially encoded cytochrome c oxidase 1 (Mt-CO1), mitochondrially encoded ATP synthase 6 (Mt-ATP6), nuclear factor(erythroidderived 2)-like 2 (NFE2L2; NRF2), NAD(P) H dehydrogenase-quinone oxidoreductase 1 (NQO1), glutamatecysteine ligase catalytic subunit (GCLC), heme oxygenase 1 (HMOX1), and glyceraldehyde-3phosphate dehydrogenase (GAPDH). Quantitative PCR (qPCR) was performed on a StepOne Plus Machine (Applied Biosystems) and analyzed using the delta-delta Ct method.
Graphs and statistics
All bar graphs have error bars reflecting standard error of the mean. Statistical significance was determined using one-or two-way analysis of variance or with appropriate t-tests. Bonferroni post-hoc tests were also conducted. Significance was defined as p ≤ 0.05. Analyses were N.E. Gray et al. Molecular and Cellular Neuroscience 93 (2018) 1-9 performed using Excel or GraphPad Prism 6.
Results
CAW attenuates Aβ-induced deficits in spatial memory
We have previously demonstrated the CAW improves spatial memory in aged (20 month old) mice, both in healthy WTs (Gray et al., 2016) as well as the Tg2576 model of Aβ accumulation (Soumyanath et al., 2012) . To validate these findings in the 5XFAD mouse line we used the object location memory (OLM) test. The OLM is a test of spatial memory wherein the mouse using identical objects one of which is moved during testing to a location distinct from where it was during training ( Fig. 2A) . If the mouse remembers the training location it should spend a greater amount of time with the object in the new location. We found that 5xFAD mice had significantly impaired spatial memory (p < 0.05) but this deficit was attenuated by CAW treatment (p < 0.05; Fig. 2B ). CAW treatment did not affect spatial memory in WT animals (Fig. 2B) .
CAW improves contextual memory in Aβ overexpressing mice
The conditioned fear response test (CFR) assesses contextual memory. In this test the amount of time a mouse freezes when placed in a chamber where it previously received a shock is measured. If the mouse remembers the association of the chamber with the foot shock it will freeze longer (Fig. 3A) . We observed that 5xFAD mice spent significantly less time freezing than their WT littermates (p < 0.01). CAW treatment restored the freezing behavior in the 5xFAD mice (p < 0.05) but had no effect on freezing in WT animals (Fig. 3B) .
CAW restores executive function in Aβ overexpressing mice
Executive function was assessed in the animals using the odor discrimination reversal learning (ORDL) test. The test occurs in two phases: acquisition and shift. The acquisition phase of the test evaluates learning while the shift phase targets executive function specifically. 5xFAD mice showed impairments in both the acquisition and shift phases of ODRL testing relative to their WT littermates, taking more trials to reach criteria in each phase of the test. Although the same trend was observed in each phase it was only statistically significant in the acquisition phase (p < 0.05). CAW treatment appeared to attenuate these deficits in the 5xFAD mice, significantly so in the shift phase (p < 0.05), but did not result in significant improvement in the WT animals (Fig. 4) .
CAW reduces Aβ plaques in the hippocampus but not cortex of 5xFAD mice
The plaque burden in the hippocampus of 5xFAD mice was significantly lower following CAW treatment (p < 0.05; Fig. 5A ). Interestingly this decrease was not apparent in the cortex of these animals (Fig. 5B) . WT animals had no measurable Aβ accumulation in any brain region (data not shown).
3.5. CAW treatment increases hippocampal and cortical expression of synaptic and antioxidant response genes 5xFAD mice had significantly reduced synaptic gene expression in both the hippocampus and frontal cortex relative to WT mice (p < 0.05). CAW treatment increased this expression in 5xFAD mice in Fig. 2 . CAW treatment improves object location memory retention in 5xFAD mice. A) Schematic of the Object Location Memory task (OLM) set up. B) At the 2 h retention time point 5xFAD mice showed significantly reduced preference for the novel location. CAW-treatment attenuated this impairment in 5xFAD mice. n = 5-7 mice in each group, *p < 0.05. Fig. 3 . CAW treatment improves contextual memory in 5xFAD mice. A) Schematic of the conditioned fear response (CFR) testing set up. B) 5xFAD mice froze significantly less in the testing phase than WT mice. CAW restored freezing behavior in 5xFAD mice to WT levels but had no effect on WT mice. Data is represented as the difference in freezing time between the test phase and the habituation phase, n = 5-7 mice in each group, *p < 0.05, **p < 0.01.
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Molecular and Cellular Neuroscience 93 (2018) 1-9 both brain regions but had no effect on WT animals ( Fig. 6A and B) . There was no consistent significant genotype effect on antioxidant gene expression although there was a trend toward a coordinate increase in expression of NRF2 and its antioxidant response element (ARE)-containing target genes in both brain regions in the 5xFAD animals relative to WT littermates and a trend toward further increase in each genotype following CAW treatment ( Fig. 6C and D) . CAW significantly increased HMOX1 and NQO1 in WT animals (p < 0.01 and p < 0.05 respectively) and increased the expression NRF2 and HMOX1 in 5xFAD mice (p < 0.05 and p < 0.01 respectively).
CAW attenuates deficits in mitochondrial gene expression and improves hippocampal mitochondrial function in Aβ overexpressing mice
There was a trend toward reduced expression of genes encoding proteins in the electron transport chain (ETC) in the hippocampus of 5xFAD mice (Fig. 6E) and a significantly reduction in the frontal cortex of these animals (p < 0.05; Fig. 6F ). CAW-treatment restored this expression to WT levels. WT animals were not affected by CAW treatment (Fig. 6E and F) . 5xFAD mice also had a deficit in hippocampal mitochondrial bioenergetics that was likewise attenuated with CAW treatment (Fig. 7A) . CAW significantly improved basal and ADP stimulated, state III, respiration in mitochondria isolated from 5xFAD mice (p < 0.001 and p < 0.05 respectively) but did not alter the respiratory control ratio (RCR, the difference between state III and oligomycin induced state IV respiration). Consistent with previous reports in isolated brain mitochondria there was only a modest increase in uncoupled or state IIIu respiration following FCCP stimulated in both genotypes. CAW did not affect the response to FCCP in either 5xFAD or WT animals. In fact CAW did not affect any of these respiratory parameters in mitochondria isolated from WT animals (Fig. 7B) .
Discussion
The cognitive-enhancing effects of Centella asiatica have been well documented in animal models as well as human trials (Gupta et al., 2003; Veerendra Kumar and G., 2003; Tiwari et al., 2008; Mato et al., 2011) . Our lab has previously reported that CAW improves performance in the Morris Water Maze (MWM) in mice exposed to Aβ as well as healthy older mice (Soumyanath et al., 2012; Gray et al., 2016) . In this study we further explore the effects of CAW on other domains of cognitive function as well as its mechanism of action.
We found that two weeks of CAW treatment prior to, and continuing throughout, behavioral testing ( Fig. 1) improved performance of 5xFAD mice in both the OLM and CFR tests. The OLM is a hippocampal dependent test of spatial memory (Cipolotti and B., 2006; Assini et al., 2009) which is known to be impaired in AD patients (Kessels et al., 2010; Moodley et al., 2015) . Contextual memory, which is assessed by CFR, is also hippocampally-mediated and is similarly impaired in AD patients (El Haj and Kessels, 2013) . Animal models of AD recapitulate the deficits in both of these tasks (Good and Hale, 2007; Dong et al., 2008; Kim et al., 2013; Yang and Tohda, 2018) . The improvement in OLM and CFR seen in this study are consistent with previous reports showing that triterpenes, a class of compound abundant in Centella asiatica (Siddiqui et al., 2007) , can prevent deficits in the same tasks in of mouse models of AD as well as in healthy aged mice (Sirichoat et al., 2015; Li et al., 2016; Loganathan and Thayumanavan, 2018) . It is also in line with studies showing that both OLM and CFR performance by cognitively impaired mice is improved by treatment with polyphenols (de Oliveira et al., 2014; Welbat et al., 2016; Yimam et al., 2016; Bassani et al., 2017) , a class of compounds which both Centella asiatica in general (Siddiqui et al., 2007; Subban et al., 2007) and CAW specifically are rich in (Soumyanath et al., 2012; Gray et al., 2014; Gray et al., 2017a) . It is likewise consistent with our lab's previous finding that CAW improved performance in the MWM, another hippocampal test of spatial memory, in the Tg2576 model of Aβ accumulation (Soumyanath et al., 2012) .
While it has previously been shown that Tg2576 mice have impaired ODRL performance (Zhuo et al., 2007; Zhuo et al., 2008) to our knowledge this is the first report of executive function impairments in the 5xFAD mouse model and the first to report improvements in executive function with an intervention in any mouse model of Aβ accumulation. Executive function includes elements like impulse control, Fig. 4 . CAW treatment improves executive function in 5xFAD mice. In the acquisition phase of the ODRL the number of trials to reach criteria was significantly increased in 5xFAD mice. The same trend was evident in the shift phase. CAW treatment reduced the number of trials to reach criteria in both phases of the ODRL although this reduction only reached statistical significance in the shift phase. n = 5-7 mice in each group, *p < 0.05. Fig. 5 . CAW reduces Aβ accumulation in the hippocampus but not the cortex of 5xFAD mice. A) CAW significantly reduced the Aβ plaque burden in the hippocampus of 5xFAD mice. B) There was no effect of CAW treatment on Aβ accumulation in the cortex. n = 10-14 mice each group, *p < 0.05.
N.E. Gray et al. Molecular and Cellular Neuroscience 93 (2018) 1-9 attention, planning, cognitive flexibility and problem solving. It is mediated by the prefrontal cortex and is very sensitive to age-related decline (Buckner, 2004; Raz and Rodrigue, 2006) . The Wisconsin Card Sorting Test (WCST) is one of a number of widely used tests to assess executive function in humans. In this task subjects are required to adapt behavioral responses to choose the "correct" stimulus array based on sudden rule changes across multiple modalities (Eling et al., 2008) . Performance in this task declines with age and is impaired in AD (SilvaFilho et al., 2007; Ashendorf and McCaffrey, 2008) . The ODRL, also called attention set shifting task, is a parallel test that has been developed for rats and, more recently, mice (Birrell and Brown, 2000; Garner et al., 2006) . Like the WCST the ODRL requires paying attention to relevant stimuli while ignoring irrelevant stimuli and subsequently shifting the attention, either within dimensions or between dimensions of the test stimuli (Birrell and Brown, 2000) . Also like the WCST performance in the ODRL declines with age and is impaired in models of AD (Barense et al., 2002; Zhuo et al., 2007; Young et al., 2009; Marchese et al., 2014) . We found that CAW treatment improved performance of 5xFAD mice in both the acquisition and shift phases of this test. The acquisition phase of the ODRL assesses classical learning and the improvement observed following CAW treatment is in line with our previous report of Fig. 6 . CAW increases mitochondrial, antioxidant and synaptic proteins in the hippocampus and cortex of 5xFAD mice. Synaptic gene expression was reduced in 5xFAD mice in the hippocampus (A) and frontal cortex (B) but this was attenuated by CAW treatment. CAW treatment also increased expression of NRF2 and its AREcontaining target genes in the hippocampus (C) and frontal cortex (D) of both 5xFAD and WT animals. 5xFAD mice had a reduction in expression of ETC genes in the hippocampus (E) and frontal cortex (F) and CAW treatment increased this expression in both brain regions. n = 8-10, *p < 0.05, **p < 0.01, ***p < 0.001.
N.E. Gray et al. Molecular and Cellular Neuroscience 93 (2018) 1-9 enhanced performance of CAW-treated Tg2576 mice in the hidden platform phase of the MWM. The shift phase of ODRL is the metric of cognitive flexibility. CAW treatment also attenuated impairments in this dimension of cognitive function in 5xFAD mice. This finding is consistent with a previous clinical trial showing that a Centella asiatica supplement improved executive function in healthy middle aged adults (Dev RDO et al., 2009) . We also observed that CAW treatment significantly reduced the Aβ plaque burden in the hippocampus of 5xFAD animals. Notably this change was not seen in the cortex. Our previous report in Tg2576 mice found that Aβ levels were unchanged in the cortex of treated animals but did not evaluate hippocampal levels (Soumyanath et al., 2012) . It is interesting that there is a regionally specific effect of CAW on Aβ however the fact that CAW-induced behavioral improvements were seen in both hippocampal-and cortically-mediated tasks suggests that a reduction in Aβ is not necessary for the cognitive enhancing effects of the extract. Our synaptic gene expression data also supports this conclusion. We found synaptic gene expression was similarly increased in both the hippocampus and cortex following CAW treatment. Since increased synaptic density is known to correlate with improved cognitive function (Terry et al., 1991) this is likely the physiological underpinning of the improvement in both the hippocampal-and corticallymediated cognitive tests seen in this study.
Interestingly there was no effect of CAW on WT animals in any of the cognitive tests. This was somewhat surprising as we have recently reported that CAW can improve performance in OLM and ODRL in aged 20 month old WT animals . It is possible that since the mice in this study were significantly younger, 7 months old, they do not have any cognitive deficits and therefore may already be maximally performing in these tasks. Indeed, this would be consistent with our previous report that CAW did failed to improve MWM behavior in young 2 month old WT mice (Gray et al., 2016) .
Increased mitochondrial dysfunction and oxidative stress are evident in the AD brain. Studies suggest that alterations in mitochondrial bioenergetics in the brain precede and may even induce cognitive decline in AD (Yao et al., 2009 ) and reduced neuronal mitochondrial function and number have been reported in AD patients (Hirai et al., 2001) . These changes in mitochondrial function have been recapitulated in many mouse models of AD including the 5xFAD mice (Devi and Ohno, 2012; Wang et al., 2016) . In this study we found that oral CAW treatment can attenuate reductions in mitochondrial gene expression and improve mitochondrial function in the hippocampus of treated 5xFAD mice. To our knowledge this is the first report of impaired in vivo mitochondrial function in the hippocampus of these animals. Interestingly we found that CAW treatment increased basal and ADP-stimulated respiration in 5xFAD hippocampal mitochondria but had no effect on RCR. RCR is a measure of how tightly coupled respiration is to phosphorylation and decreases in RCR are associated with lower capacity for substrate oxidation and ATP turnover (Iuso et al., 2017) . The fact that CAW affects basal and maximal ADP-stimulated respiration but not RCR may reflect an increase in mitochondrial content following CAW treatment, rather than increased the activity or efficiency of individual ETC enzymes. The coordinate induction of mitochondrial genes by CAW seen in this study is also consistent with increased mitochondrial number; however further studies using electron microscopy are necessary to definitively confirm an effect of CAW on mitochondrial biogenesis. These studies are currently underway in our lab.
It would also be interesting in future experiments to profile the bioenergetics of mitochondria isolated from different brain regions. Our gene expression data suggests CAW has a global effect on mitochondrial gene expression but it is possible that it could have regionally specific effect on activity. If there is specificity to the activity change that would provide evidence that mitochondrial effect is independent of the cognitive enhancing effects of CAW as we did observe behavioral improvements in tasks mediated by multiple brain regions.
Antioxidant gene expression was also increased with CAW treatment. Both hippocampal and cortical expression of the transcription factor NRF2 and its target genes were all upregulated in the brains of treated WT and 5xFAD mice. NRF2 regulates the endogenous antioxidant response pathway by increasing the expression cytoprotective genes (Motohashi and Yamamoto, 2004) . NRF2 expression and activity has been reported to be altered in AD (Ramsey et al., 2007) and activation of NRF2 by various compounds has been shown to protect against Aβ-induced cell death (Kanninen et al., 2008) and improve mitochondrial function in healthy mice and human neuroblastoma cells (Hayashi et al., 2017) . It remains to be seen what role the activation of NRF2 plays in the cognitive enhancing and mitochondrial effects of CAW but experiments are underway in the lab to evaluate the effects of the extract on NRF2KO mice to address these questions.
Although women are disproportionately affected by AD, men do make up about one third of AD patient. Studies are underway in our lab to confirm the results seen in this study in male mice to inform the potential therapeutic utility of CAW in both genders. Additionally because CAW is a complex mixture it is of great interest to determine which compounds within the extract are responsible for its various effects. We have previously demonstrated that triterpenes and caffeoylquinic acids from CAW activate NRF2 and improve mitochondrial function in neuroblastoma cells exposed to Aβ (Gray et al., 2015) and these same compounds increase synaptic density in neurons isolated from Aβ-overexpressing animals (Gray et al., 2017a) . Studies are ongoing to determine the cognitive and mitochondrial effects of these compounds in vivo. A) The bioenergetic profile of 5xFAD mice, as determined by Seahorse XF analyzer, was impaired relative to WT mice and CAW treatment partially attenuated this impairment. B) CAW reduced the deficit in both basal and maximal respiration in hippocampal mitochondria isolated from 5xFAD mice but had no effect on RCR. n = 4-5 per group, *p < 0.05, **p < 0.01, ***p < 0.001.
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Conclusions
This study further demonstrates the cognitive enhancing effects of CAW. Relatively short treatment with the extract increased the expression of synaptic genes and improved several different domains of cognitive performance in 5xFAD animals, including learning, memory and executive function. These cognitive-enhancing effects appear independent of Aβ plaque reduction because while CAW reduced the Aβ plaque burden in the hippocampus, it did not affect Aβ levels in the cortex, yet improvements were observed in both hippocampal and cortically mediated tasks. CAW treatment also improved hippocampal mitochondrial function and induced the expression of mitochondrial as well as antioxidant response genes in the brains of 5xFAD mice. While the exact relationship between these effects remains to be elucidated, as well as which compounds from the extract are responsible for each effect, the fact that synaptic dysfunction and cognitive impairment accompany oxidative stress and mitochondrial dysfunction in many neurological conditions as well as in healthy aging suggests a therapeutic potential for CAW beyond AD.
